title: The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.
authors.affiliation: Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan, rhorii-pathology@jfcr.or.jp.
authors.forename: Rie
authors.initials: R
authors.lastname: Horii
authors.forename: Naoko
authors.initials: N
authors.lastname: Honma
authors.forename: Akiko
authors.initials: A
authors.lastname: Ogiya
authors.forename: Yuji
authors.initials: Y
authors.lastname: Kozuka
authors.forename: Takayo
authors.initials: T
authors.lastname: Fukuda
authors.forename: Masayuki
authors.initials: M
authors.lastname: Yoshida
authors.forename: Shozo
authors.initials: S
authors.lastname: Ohsumi
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Mukai
mesh_terms: D044963:Biopsy, Fine-Needle; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D018365:Neoplasm, Residual; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D021701:Sentinel Lymph Node Biopsy
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human